Intrinsiqq
Ascendis Pharma A/S logo

Ascendis Pharma A/S Insider Trading

ASND

Compare
Last 12 months

Insiders bought 777K and sold $10.8M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. EVP & Chief Admin Officer Anni Lotte Kirstine Sonderbjerg Pedersen sold $5.28M on Nov 17, 51% of their stake, outside a plan.

Net open-market
−$10M
5 buys · 4 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
2 / 4
executives and directors
Last open-market buy
Aug 2026
Aug 14, 2026

Get an email when ASND's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 17No plan
    Anni Lotte Kirstine Sonderbjerg Pedersen
    EVP & Chief Admin Officer · sold 20,000 at $263.89
    $5.28M
    51% of stake
  • Sep 8No plan
    Mads Bodenhoff
    SVP & Pao · sold 3,000 at $270.19
    811K
    100% of stake
  • Sep 2No plan
    Lars Holtug
    Director · sold 236 at $264.13
    62K
    5.6% of stake
  • Aug 14
    Jean Jacques Bienaime
    Director · bought 2,000 at avg $246.33
    493K
    222% of stake
  • Jun 2
    Scott Thomas Smith
    EVP & Chief Financial Officer · bought 100 at $219.00
    22K
    2.3% of stake
  • May 29
    Jean Jacques Bienaime
    Director · bought 500 at avg $223.12
    112K
    125% of stake
  • May 29
    Scott Thomas Smith
    EVP & Chief Financial Officer · bought 250 at $223.32
    56K
    6.2% of stake
  • May 26
    Jean Jacques Bienaime
    Director · bought 400 at avg $237.81
    95K
    New position
  • May 11No plan
    Flemming Steen Jensen
    See Remarks · sold 19,460 at $238.49
    $4.64M
    100% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ASND, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biotechnology · Pick stocks to compare with ASND

CompareIntrinsic value
LKFT.XAMSLakefront Biotherapeutics
€30.38-1.62%28
GLPGGalapagos NV American Depositary Receipt
$33.39-2.00%61
LMRILumexa Imaging Holdings, Inc.
$14.10+0.25%42
SFL.XMILSafilo Group S.p.A.
€2.06-6.78%69
SUS.XSTOSurgical Science Sweden AB
kr 59.75+0.76%37
DOCM.XSWXDocMorris AG
CHF 18.63-0.90%26
FAGR.XBRUFagron NV
€24.65+1.02%78
DMP.XETRDermapharm Holding SE
€32.75-2.09%49

Held by ETFs

ASND is in 59 US ETFs. The largest of them, with ASND's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ASND

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.